The Candidate Oncogene CYP24A1: A Potential Biomarker for Colorectal Tumorigenesis

被引:109
作者
Horvath, Henrik C. [2 ]
Lakatos, Peter [2 ]
Kosa, Janos P. [2 ]
Bacsi, Krisztian
Borka, Katalin
Bises, Giovanna [1 ]
Nittke, Thomas [1 ]
Hershberger, Pamela A. [3 ]
Speer, Gabor [2 ]
Kallay, Enikoe [1 ]
机构
[1] Med Univ Vienna, Dept Pathophysiol, A-1090 Vienna, Austria
[2] Semmelweis Univ, Dept Med 1, H-1085 Budapest, Hungary
[3] Univ Pittsburgh, Inst Canc, Pittsburgh, PA USA
关键词
colorectal cancer; CYP24A1; vitamin D receptor; vitamin D; proliferation; Ki-67; adenoma; polyp; adenocarcinoma; VITAMIN-D SYSTEM; COMPARATIVE GENOMIC HYBRIDIZATION; PROSTATE-CANCER CELLS; HUMAN COLON; 25-HYDROXYVITAMIN D-3-1-ALPHA-HYDROXYLASE; D HYDROXYLASES; MESSENGER-RNA; BREAST-CANCER; D METABOLISM; IN-VIVO;
D O I
10.1369/jhc.2009.954339
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The main autocrine/paracrine role of the active metabolite of vitamin D-3, 1 alpha,25-dihydroxyvitamin D-3 (1,25-D-3), is inhibition of cell growth and induction of cell differentiation and/or apoptosis. Synthesis and degradation of the secosteroid occurs not only in the kidney but also in normal tissue or malignant extrarenal tissues such as the colon. Because 25-hydroxyvitamin D-3 24-hydroxylase (CYP24A1) is considered to be the main enzyme determining the biological half-life of 1,25-D-3, we have examined expression of the CYP24A1 mRNA (by real-time RT-PCR) and protein (by immunohistochemistry) in normal human colon mucosa, colorectal adenomas, and adenocarcinomas in 111 patients. Although 76% of the normal and benign colonic tissue was either completely devoid of or expressed very low levels of CYP24A1, in the majority of the adenocarcinomas (69%), the enzyme was present at high concentrations. A parallel increased expression of the proliferation marker Ki-67 in the same samples suggests that overexpression of CYP24A1 reduced local 1,25-D-3 availability, decreasing its antiproliferative effect. (J Histochem Cytochem 58:277-285, 2010)
引用
收藏
页码:277 / 285
页数:9
相关论文
共 52 条
[1]   Prostate cancer risk and prediagnostic serum 25-hydroxyvitamin D levels (Finland) [J].
Ahonen, MH ;
Tenkanen, L ;
Teppo, L ;
Hakama, M ;
Tuohimaa, P .
CANCER CAUSES & CONTROL, 2000, 11 (09) :847-852
[2]   Expression of VDR and CYP24A1 mRNA in human tumors [J].
Anderson, MG ;
Nakane, M ;
Ruan, XA ;
Kroeger, PE ;
Wu-Wong, JR .
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2006, 57 (02) :234-240
[3]   25-hydroxy-vitamin D metabolism in human colon cancer cells during tumor progression [J].
Bareis, P ;
Bises, G ;
Bischof, MG ;
Cross, HS ;
Peterlik, M .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2001, 285 (04) :1012-1017
[4]   Plasma 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D and risk of breast cancer [J].
Bertone-Johnson, ER ;
Chen, WY ;
Holick, MF ;
Hollis, BW ;
Colditz, GA ;
Willett, WC ;
Hankinson, SE .
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2005, 14 (08) :1991-1997
[5]   25-hydroxyvitamin D3-1α-hydroxylase expression in normal and malignant human colon [J].
Bises, G ;
Kállay, E ;
Weiland, T ;
Wrba, F ;
Wenzl, E ;
Bonner, E ;
Kriwanek, S ;
Obrist, P ;
Cross, HS .
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY, 2004, 52 (07) :985-989
[6]   Cancer incidence and mortality in Europe, 2004 [J].
Boyle, P ;
Ferlay, J .
ANNALS OF ONCOLOGY, 2005, 16 (03) :481-488
[7]   De-orphanization of cytochrome P450 2R1 - A microsomal vitamin D 25-hydroxylase [J].
Cheng, JB ;
Motola, DL ;
Mangelsdorf, DJ ;
Russell, DW .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (39) :38084-38093
[8]  
Cross Heide S, 2005, Future Oncol, V1, P415, DOI 10.1517/14796694.1.3.415
[9]   Vitamin D metabolism in human colon adenocarcinoma-derived Caco-2 cells: Expression of 25-hydroxyvitamin D-3-1 alpha-hydroxylase activity and regulation of side-chain metabolism [J].
Cross, HS ;
Peterlik, M ;
Reddy, GS ;
Schuster, I .
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 1997, 62 (01) :21-28
[10]   Vitamin D signalling pathways in cancer: potential for anticancer therapeutics [J].
Deeb, Kristin K. ;
Trump, Donald L. ;
Johnson, Candace S. .
NATURE REVIEWS CANCER, 2007, 7 (09) :684-700